Navigation Links
L.A. Zoo Announces Successful Cancer Treatment of Rhinoceros With Electronic Brachytherapy

LOS ANGELES, Nov. 16 /PRNewswire/ -- The Los Angeles Zoo announced that Randa, a 40-year-old Indian rhinoceros, has successfully completed treatment for skin cancer using a breakthrough cancer treatment platform designed to deliver electronic, x-ray based therapy directly to cancer sites with minimal radiation exposure to surrounding healthy tissue.


Randa was recently diagnosed with recurrent squamous cell carcinoma under her horn, a form of skin cancer. To deliver Randa's treatment, Zoo veterinary staff worked closely with oncology surgeons and radiation oncologists from UCLA Medical Center, as well as scientists from Xoft, Inc., makers of the Axxent® Electronic Brachytherapy, eBx(TM), System. Her treatments were in two sessions, or radiation fractions. Since the eBx treatment does not use a radioactive isotope, it can be performed without the need for a lead shielded room. This enabled the Zoo veterinarians and radiation oncologists from UCLA to remain with Randa during treatment, ensuring her safety and the accurate delivery of treatment.

"We are very happy with the outcome of Randa's cancer treatment and her recovery. After the treatment sessions were completed, she quickly returned to her normal attitude; acting years younger and entertaining Zoo visitors," said Leah Greer, DVM and Randa's primary veterinarian at the L.A. Zoo. "When you're talking about a 4,000 pound animal, you have to balance the safety of the animal and the safety of the Zoo staff with the logistics of the treatment. In Randa's case, we clearly wanted to eradicate the cancer, but we had to consider where the treatment could be performed and how long it would take. The ability to roll the fully functional Electronic Brachytherapy cancer treatment system into Randa's habitat gave us the ability to provide quick, safe and accurate treatment. I don't know that we would have been able to reach such a positive prognosis without it, as there is no way we could have transported Randa to a traditional lead shielded room for radiation treatment."

"We were extremely proud to work with the Zoo's veterinarians in the planning and treatment management of Randa. Although the coordination of care was very complex, the treatment delivery of the electronic brachytherapy went very smoothly," said Michael Steinberg, MD, chair of the UCLA department of radiation oncology. "We recently had incorporated this groundbreaking electronic brachytherapy treatment option for patients in our clinic at the Ronald Reagan UCLA Medical Center and we were particularly gratified to bring its benefits of this technology to our colleagues at the L.A. Zoo."

Designed for the delivery of radiation oncology in medical and veterinary practices, the Axxent System is cleared by the U.S. Food & Drug Administration (FDA) for accelerated treatment of early stage breast cancer, skin cancer and endometrial indications. As a platform technology, the Axxent System is designed to deliver non-radioactive therapy directly to cancer sites with minimal radiation exposure to surrounding healthy tissue.

"We are proud to make our Electronic Brachytherapy technology available to treat Randa and are especially pleased that she recovered so quickly," said Michael Klein, Xoft president and CEO. "Through its use in the treatment of breast and endometrial cancers, Electronic Brachytherapy has shown the proven ability to deliver a high treatment dose to a cancer tumor while sparing nearby normal tissue. It is very gratifying that advancements in treating cancer in people can now lead to improvements in animal care as well - at the Zoo and in general veterinary practices."

"I am especially proud to be part of the team that performed this ground breaking new technology on Randa. We are definitely seeing positive results post treatment and hope that it results in a permanent cure with no recurrence. This case is a perfect example of how tremendous the community support is for the L.A. Zoo and I am especially thankful to all those involved in making this a successful procedure," said Dr. Curtis Eng, Los Angeles Zoo chief veterinarian.

About the Los Angeles Zoo

The Los Angeles Zoo and Botanical Gardens is located in Griffith Park at the junction of the Ventura (134) and Golden State (5) freeways. Admission is $13 for adults and $8 for children ages 2 to 12. The Zoo is open from 10 a.m. to 5 p.m. daily. For information, call (323) 644-4200 or visit the L. A. Zoo Web site at

About Xoft, Inc.

Xoft, founded in 1998, develops Electronic Brachytherapy (eBx) systems based upon miniaturized X-ray tube technology for the practice of radiation oncology in virtually any clinical setting, eliminating the need for heavily shielded environments. The Axxent treatment platform provides a therapeutic dose of radiation directly to the region at risk with minimal radiation exposure to surrounding healthy tissue and without the complex handling, resource logistics and costs associated with using radioactive isotopes. Xoft aligns with the Nuclear Regulatory Commission's (NRC) directive to seek alternatives for radioactive medical isotopes. For more information, visit

Axxent is a registered trademark and eBx is a trademark of Xoft, Inc.

SOURCE Xoft, Inc.

SOURCE Xoft, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Personalized Pharmaceutical Systems Announces Sale of Angioedema Clinical Prediction Guide to Viropharma Incorporated
2. QRxPharma Limited Announces A$21.6 Million Fully Underwritten Capital Raising
3. AMD LASERS Announces the Addition of Bart Waclawik, New Chief Operating Officer
4. Shire Announces Publication of Open-Label Study on Coadministration of INTUNIV(TM) (guanfacine) Extended-Release Tablets with Stimulants
5. Cardo Medical, Inc. Announces Closing of $6.2 Million Private Placement
6. Misonix Announces New Distribution Agreement for Argentina
7. nContact Announces Initiation of Clinical Trials for the Treatment of Atrial Fibrillation in Open-Chest Procedures
8. China Medicine Announces Strong Third Quarter 2009 Results
9. Jiangbo Pharmaceuticals, Inc. Announces Conference Call to Discuss Results for the First Quarter of Fiscal Year 2010
10. Chindex International Announces Participation in Brean Murray, Carret & Co. 2009 China Growth Conference
11. LifeCare Holdings, Inc. Announces Third Quarter Results
Post Your Comments:
(Date:11/30/2015)... Nov. 30, 2015 Next week, December 2-3, ... Things (DoT ) co-located events covering the latest in ... of Things, will draw more than 3,000 design industry ... Convention Center. The events, combined show floor will host ... --> --> BIOMEDevice ...
(Date:11/30/2015)... global cell culture market is expected to grow ... 2022 at a CAGR of 7.1% therein. --> global ... value of US$6.1 bn to US$11.3 bn by 2022 at a ... announced the release of a new market research study, detailing the ... Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast ...
(Date:11/30/2015)...  IBA Molecular North America, Inc. (IBAMNA), a U.S. ... that as of January 1, 2016, it will do ... to rebrand the company reflects a refined vision for ... close relationship with Zevacor Molecular.  Both IBAMNA and Zevacor ... Peter Burke , Vice President Sales ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... November 30, 2015 , ... The Foundation ... cancer education and prevention—is joining forces with the award-winning creator and writer of ... on December 7, 2015 at the Union League of Philadelphia. , The ...
(Date:11/30/2015)... ... , ... The American Society for Clinical Pathology (ASCP) announced today that it ... Nov. 30, ASCP shared its “Give a minute. Get tested. Find a cure.” icon ... of getting tested for HIV. , ASCP has asked members to replace their Facebook, ...
(Date:11/30/2015)... ... November 30, 2015 , ... Brenntag ... exclusive channel partner for the Nutraceutical Specialties products into oral solid dosage in ... immediately. , “We are pleased to announce our expanded distribution agreement with ...
(Date:11/30/2015)... ... November 30, 2015 , ... According ... Hansen, Ph.D., a senior scientist at Consumer Reports as supporting a “A Call ... child’s exposure limits. , The original Nov 2015 CR story titled, “Does Cell-Phone ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... last 15 years, announced today that Michigan-based Family Health Center (FHC) has selected ... over 45 years, FHC was awarded the largest Affordable Care Act grant for ...
Breaking Medicine News(10 mins):